Urmăriți
Paul-Adrian Chiroi
Paul-Adrian Chiroi
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania
Adresă de e-mail confirmată pe umfcluj.ro
Titlu
Citat de
Citat de
Anul
Cancer-associated stemness and epithelial-to-mesenchymal transition signatures related to breast invasive carcinoma prognostic
IM Groza, C Braicu, A Jurj, O Zanoaga, R Lajos, P Chiroi, R Cojocneanu, ...
Cancers 12 (10), 3053, 2020
182020
Cellular and molecular profiling of tumor microenvironment and early-stage lung cancer
R Pirlog, P Chiroi, I Rusu, AM Jurj, L Budisan, C Pop-Bica, C Braicu, ...
International journal of molecular sciences 23 (10), 5346, 2022
162022
The role of miR-155 in nutrition: modulating cancer-associated inflammation
O Zanoaga, C Braicu, P Chiroi, N Andreea, NA Hajjar, S Mărgărit, ...
Nutrients 13 (7), 2245, 2021
142021
Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in oral squamous cell carcinoma: a potential biomarkers panel?
O Aghiorghiesei, O Zanoaga, L Raduly, AI Aghiorghiesei, P Chiroi, A Trif, ...
Current issues in molecular biology 44 (4), 1754-1767, 2022
92022
The implications of noncoding rnas in the evolution and progression of nonalcoholic fatty liver disease (Nafld)-related hcc
I Rusu, R Pirlog, P Chiroi, A Nutu, VR Puia, AC Fetti, DR Rusu, ...
International Journal of Molecular Sciences 23 (20), 12370, 2022
82022
Comprehensive analysis of the expression of key genes related to Hippo signaling and their prognosis impact in ovarian cancer
P Kubelac, C Braicu, L Raduly, P Chiroi, A Nutu, R Cojocneanu, ...
Diagnostics 11 (2), 344, 2021
72021
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
BO Pirlog, S Ilut, R Pirlog, P Chiroi, A Nutu, DI Radutiu, GD Cuc, ...
Expert Reviews in Molecular Medicine, 1-51, 2023
42023
Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms
E Isacescu, P Chiroi, O Zanoaga, A Nutu, L Budisan, R Pirlog, ...
Antioxidants 12 (2), 407, 2023
42023
C,O‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity
AA Someșan, SM Vieriu, A Crăciun, C Silvestru, P Chiroi, A Nutu, A Jurj, ...
Applied Organometallic Chemistry 36 (3), e6540, 2022
32022
Microarrays and NGS for drug discovery
LA Pop, O Zanoaga, P Chiroi, A Nutu, SS Korban, C Stefan, A Irimie, ...
Drug Design-Novel Advances in the Omics Field and Applications, 2021
22021
Vinorelbine Alters lncRNA Expression in Association with EGFR Mutational Status and Potentiates Tumor Progression Depending on NSCLC Cell Lines’ Genetic Profile
H Alsharoh, P Chiroi, A Nutu, L Raduly, O Zanoaga, I Berindan-Neagoe
Biomedicines 11 (12), 3298, 2023
12023
Identification of a miRNA panel with a potential determinant role in patients suffering from periodontitis
O Baru, L Raduly, C Bica, P Chiroi, L Budisan, N Mehterov, C Ciocan, ...
Current issues in molecular biology 45 (3), 2248-2265, 2023
12023
Non-Coding RNAs and Reactive Oxygen Species–Symmetric Players of the Pathogenesis Associated with Bacterial and Viral Infections
Z Milhem, P Chiroi, A Nutu, M Ilea, M Lupse, O Zanoaga, ...
Symmetry 13 (7), 1307, 2021
12021
Profiling canine mammary tumors: A potential model for studying human breast cancer
LM Gherman, P Chiroi, A Nuțu, C Bica, I Berindan-Neagoe
The Veterinary Journal, 106055, 2023
2023
Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis.
I Rusu, R Pirlog, P Chiroi, A Nutu, L Budisan, VR Puia, C Braicu, ...
Journal of Gastrointestinal & Liver Diseases 32 (3), 2023
2023
Alteration of the miR-21, miR-155 and miR-181a expression level in breast cancer: implications in the immune response and possible prognostic value.
P Chiroi, E Isăcescu, M Groza, C Ciocan, C Bica, OL Pop, C Braicu, ...
Oncolog-Hematolog, 2023
2023
Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?
R Pirlog, P Chiroi, L Raduly, A Nutu, A Cismaru, I Berindan-Neagoe
2023
Tumor Microenvironment Characterization as a Source of Novel Molecular Biomarkers in Early-stage Lung Cancer
R Pirlog, I Rus, P Chiroi, A Jurj, L Budisan, I Neagoe, D Crisan, ...
LABORATORY INVESTIGATION 102 (SUPPL 1), 1336-1338, 2022
2022
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–18